Merck signs royalty-free deal to expand access to its Covid-19 pill
Move contrasts with mRNA makers Pfizer and Moderna, which have rejected sharing vaccine technology
Move contrasts with mRNA makers Pfizer and Moderna, which have rejected sharing vaccine technology